On Thursday, 10 July 2025, from 10:30 to 12:00, the Intergroup on Cancer and Rare Diseases will host a public hearing at the European Parliament in Strasbourg (Room N3.1) to explore the ongoing reform of the pharmaceutical legislation in Europe. 

Co-chaired by MEP Tomislav Sokol (EPP, HR), MEP Vlad Voiculescu (RE, RO), MEP Tilly Metz (Greens/EFA, LU), MEP Stine Bosse (RE, DK), and MEP Alessandra Moretti (S&D, IT), the event will address how the new framework can:

• Better support access to innovation to make sure technological advancements reach the patients in need

• Strengthen incentives for still underserved populations

• Ensure that patients’ needs remain at the centre of EU health policy and their expertise contribute actively to shape better decisions

The hearing will serve as a forum for exchanges and discussions on the position that the Parliament should adopt in the final stage of the Revision of the General Pharmaceutical Legislation to ensure the needs of cancer, rare disease and childhood cancer patients are met. Topics on our agenda will include:

• The modulation of regulatory incentives

• The "first-in-child" approach

• Treatment optimisation 

• Addressing unmet medical needs

• Give value to patients expertise and promote participation

The meeting will bring together voices from across the healthcare landscape, including patient advocates, academic experts, health insurers, and regulatory representatives. With contributions from leading organisations and plenty of space for exchange, this is an opportunity for sharing key insights with the European Parliament and collaboratively shaping the path ahead for trilogues.

The event is open to all and does not require registration, however please note an accredited access badge to the European Parliament is required.  forward to welcoming you in Strasbourg.